Weekly CEO Sells Highlight: Universal Insurance Holdings Inc, Avanir Pharmaceuticals Inc, Bel Fuse Inc, and NewLink Genetics Corp.

Author's Avatar
Jun 30, 2012
According to GuruFocus Insider Data, these are the largest CEO sales during the past week: Universal Insurance Holdings Inc, Avanir Pharmaceuticals Inc, Bel Fuse Inc, and NewLink Genetics Corp. Universal Insurance Holdings, Inc. (UVE, Financial): CEO, 10% Owner Bradley I Meier sold 1,500,000 Shares

CEO, 10% Owner of Universal Insurance Holdings, Inc. (UVE) Bradley I Meier sold 1,500,000 shares on 06/22/2012 at an average price of $3.15. Universal Insurance Holdings, Inc., through its wholly-owned subsidiary, Universal Property & Casualty Insurance Company (UPCIC), is currently engaged in insurance underwriting, distribution and claims. Universal Insurance Holdings, Inc. has a market cap of $133.6 million; its shares were traded at around $3.4 with a P/E ratio of 5.3 and P/S ratio of 0.6. The dividend yield of Universal Insurance Holdings, Inc. stocks is 12.1%. Universal Insurance Holdings, Inc. had an annual average earnings growth of 0.3% over the past 5 years.

Universal Insurance Holdings reported net income of $9.9 million of $0.24 per diluted share and premium earned and other revenue of $60.2 million for the first financial quarter of 2012.

CEO, 10% Owner Bradley I Meier sold 1,550,000 shares of UVE stock in June.

Avanir Pharmaceuticals, Inc. (AVNR, Financial): President and CEO Keith Katkin sold 190,125 Shares

President and CEO of Avanir Pharmaceuticals, Inc. (AVNR) Keith Katkin sold 190,125 shares on 06/25/2012 at an average price of $3.5. AVANIR Pharmaceuticals is focused on developing, acquiring and commercializing novel therapeutic products for the treatment of chronic diseases. Avanir Pharmaceuticals, Inc. has a market cap of $470.9 million; its shares were traded at around $3.9 with and P/S ratio of 44.9.

Avanir Pharmaceuticals Inc. reported their 2012 second quarter fiscal results. The Company reported net revenue of $10.0 million and net loss of $17.0 million.

President and CEO Keith Katkin bought 10,000 and sold 190,125 shares of AVNR stock in March and June.SVP, R&D Joao Md Siffert bought 2,700 shares of AVNR stock on 05/10/2012 at the average price of 2.96. Vice President, Finance Christine Ocampo bought 3,000 shares of AVNR stock on 03/06/2012 at the average price of 2.6. Director Charles Mathews bought 5,000 shares of AVNR stock on 03/06/2012 at the average price of 2.69.

Bel Fuse, Inc. (BELFB, Financial): President and CEO Daniel Bernstein sold 171,185 Shares

President and CEO of Bel Fuse, Inc. (BELFB) Daniel Bernstein sold 171,185 shares on 06/22/2012 at an average price of $16.81. Bel Fuse Inc. is engaged in the design, manufacture and sale of products used in networking, telecommunication, automotive and consumer electronic applications. Bel Fuse, Inc. has a market cap of $36.6 million; its shares were traded at around $17.48 with a P/E ratio of 42 and P/S ratio of 0.1. The dividend yield of Bel Fuse, Inc. stocks is 1.7%. Bel Fuse, Inc. had an annual average earnings growth of 30% over the past 5 years.

Bel Fuse Inc. reported net income of $876 thousand and revenue of $65.6 million for the Company’s 2012 first quarter.

President and CEO Daniel Bernstein sold 171,185 shares of BELFB stock on 06/22/2012 at the average price of 16.81. Director Howard Bernstein sold 1,000 shares of BELFB stock on 06/05/2012 at the average price of 15.62.

NewLink Genetics Corp (NLNK, Financial): Chairman of the Board and CEO, 10% Owner Charles J. Jr. Link sold 150,000 Shares

Chairman of the Board and CEO, 10% Owner of NewLink Genetics Corp (NLNK) Charles J. Jr. Link sold 150,000 shares on 06/21/2012 at an average price of $15.66. NewLink Genetics Corporation is a biopharmaceutical company which focuses on discovering, developing and commercializing immunotherapeutic products for cancer treatment. Newlink Genetics Corp has a market cap of $347 million; its shares were traded at around $16.57 with and P/S ratio of 185.3.

NewLink Genetics Corp. reported net loss of $4.8 million and grant revenue of $471,000 for thier first quarter of 2012.

Chairman of the Board and CEO, 10% Owner Charles J. Jr. Link sold 150,000 shares of NLNK stock on 06/21/2012 at the average price of 15.66. CFO Gordon H Jr Link sold 5,187 shares of NLNK stock on 06/15/2012 at the average price of 15.49.

For the complete list of stocks that bought by their CEOs, go to: Insider Buys.